Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-25

Clinical Trial Update: Topical Insulin for Glaucoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial from Stanford evaluating topical insulin as a treatment for glaucoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical Insulin (insulin)

Snippet

Sponsor: Stanford University | Conditions: Glaucoma | Phase 1 | Status: RECRUITING